Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies (Q26795984)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26295044%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Antonio L Teixeira

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26295044%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Aline Silva de Miranda

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26295044%20AND%20SRC:MED&resulttype=core&format=json

BioMed Research International

1 June 2020

language of work or name

English

0 references

publication date

29 July 2015

6 references

25 April 2019

19 June 2019

12 September 2019

19 November 2020

19 July 2021

8 October 2022

8 references

25 April 2019

19 June 2019

12 September 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26295044%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

19 November 2020

19 July 2021

8 October 2022

2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26295044%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

628192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26295044%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

1 June 2020

copyright license

6 references

25 April 2019

19 June 2019

12 September 2019

19 November 2020

19 July 2021

on focus list of Wikimedia project

8 October 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Use of ibuprofen and risk of Parkinson disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Regulation of LRRK2 expression points to a functional role in human monocyte maturation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Genomic determinants of motor and cognitive outcomes in Parkinson's disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Cognitive Status Correlates with CXCL10/IP-10 Levels in Parkinson's Disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

The international incidence and prevalence of neurologic conditions: how common are they?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

The prevalence of Parkinson's disease: a systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Pharmacological treatment of Parkinson disease: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Animal models of neurodegenerative diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Animal models of Parkinson's disease: limits and relevance to neuroprotection studies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

LRRK2 inhibition attenuates microglial inflammatory responses

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Vaccination for Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Genetic marker linking inflammation with sporadic Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Genome-wide association study confirms extant PD risk loci among the Dutch

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Neuroinflammation in the living brain of Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Peripheral inflammatory biomarkers and risk of Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Inflammation and the degenerative diseases of aging

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

An essay on the shaking palsy. 1817.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Apoptosis of peripheral blood lymphocytes in Parkinson patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Peripheral cytokines profile in Parkinson's disease.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Neuropsychiatric effects and type of IFN-alpha in chronic hepatitis C.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Evaluation of interleukins, ACTH, cortisol and prolactin concentrations in the blood of patients with parkinson's disease.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Defective production of interleukin-2 in patients with idiopathic Parkinson's disease.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532803

Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains

31 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Axonal transport of human immunodeficiency virus type 1 envelope protein glycoprotein 120 is found in association with neuronal apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Association of interleukin-1 beta polymorphisms with idiopathic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Complex deregulation and expression of cytokines and mediators of the immune response in Parkinson's disease brain is region dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Microglial activation and dopamine terminal loss in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

[11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Interleukin-6 serum levels in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Circulating interleukin-10 and interleukin-12 in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Acute dystonia during pegylated interferon alpha therapy in a case with chronic hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha2b: a report of two cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Association of Parkinson's disease with infections and occupational exposure to possible vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Alterations of T-lymphocyte populations in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Rheumatoid arthritis accompanied by Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Amantadine in Parkinson's disease: lymphocyte subsets and IL-2 secreting T cell precursor frequencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

NSAID use and risk of Parkinson disease: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease

21 January 2018

1 reference

12 December 2020

Serum inflammatory biomarkers in Parkinson's disease.

1 reference

12 December 2020

Toward a redefinition of Parkinson's disease

1 reference

12 December 2020

[Immune factors or depression? Fatigue correlates in Parkinson's disease]

1 reference

12 December 2020

Antidopaminergic antibodies in a patient with a complex autoimmune disorder and rapidly progressing Parkinson's disease

1 reference

12 December 2020

Nitric oxide synthase and neuronal vulnerability in Parkinson's disease.

1 reference

12 December 2020

Natural killer cells of Parkinson's disease patients are set up for activation: a possible role for innate immunity in the pathogenesis of this disease

1 reference

12 December 2020

Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease.

1 reference

12 December 2020

Parkinson’s disease is associated with increased serum levels of macrophage migration inhibitory factor

1 reference

12 December 2020

Rheumatoid-like hand deformities in Parkinson disease

1 reference

12 December 2020

Serum levels of chemokines in Parkinson's disease

1 reference

12 December 2020

Reduced T helper and B lymphocytes in Parkinson's disease

1 reference

12 December 2020

Inflammatory cytokines and NT-proCNP in Parkinson's disease patients

1 reference

12 December 2020

Effects of amantadine treatment on in vitro production of interleukin-2 in de-novo patients with idiopathic Parkinson's disease.

1 reference

12 December 2020

Increased oxidative stress in lymphocytes from untreated Parkinson's disease patients.

1 reference

12 December 2020

1 reference

12 December 2020

Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: A retrospective cohort study

1 reference

12 December 2020

1 reference

12 December 2020

The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity

1 reference

12 December 2020

Genetic analysis of immunomodulating factors in sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F628192

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1155/2015/628192

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26295044%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26295044%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26295044%20AND%20SRC:MED&resulttype=core&format=json